Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia

Clinical trial NCT02110394 · COMPLETED

Trial details

NCT number: NCT02110394
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2012-06-01
Primary completion: 2015-08-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.